Wistar scientists discover a new way to boost a person's imm

Due to the development of resistance to chemotherapy and recurring tumors, patients with ovarian cancer often have low survival rates.

Related Keywords

Rugang Zhang , Sergey Karakashev , Emily Henderson , Cancer Immunology Research , Ronald Caplan Cancer Center , Microenvironment Metastasis Program , Wistar Institute , Metastasis Program , Immune Response , Ntigen , Dancer , Cancer Treatment , Fell , Chemotherapy , Efficacy , Genes , Immune System , Immunity , Mmunology , N Vitro , N Vivo , Metastasis , Ovarian Cancer , Mh , Research , Humor ,